期刊文献+

血脂及血清载脂蛋白AⅠ、B测定对冠心病诊断的意义 被引量:1

The Significance of Diagnosing Coronary Heart Disease with Determing Plasma Lipoprotein and Apolipoprotein A1、B
下载PDF
导出
摘要 目的:测定冠心病患者和健康人的血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和载脂蛋白(apo)AⅠ、B及其比值,比较这些项目在两组间的差异,旨在研究载脂蛋白(apo)AⅠ、B比值与其余各项指标对冠心病的诊断价值。方法:随机选择冠心病患者40人,中位年龄62岁;健康人50人,中位年龄58岁,两组中性别无显著差异,用Olympus全自动生化分析仪分别测这两组的TC、TG、HDL-C、LDL-C、apoAⅠ、B。结果:用统计学方法处理所得结果,并做比较分析。发现冠心病组的TC、TG、LDL-C、apoB都明显高于健康人组(P<0.01),而HDL-C、apoAⅠ/apoB明显低于健康人组,且在各项目对冠心病的预测值有效率中,apoAⅠ/apoB的有效率最高(75.6%)。结论:apoAⅠ/apoB对于临床上诊断冠心病有重要价值。 Objective: To determine the plasma level of lipoprotein and apolipoprotein AⅠ ,B, and find out the difference of the plasma level of lipoprotein and apolipoprotein A Ⅰ , B in patients with coronary heart disease and healthy people. Methods: 40 patients with coronary heart disease and 50 healthy people were randomly divided into two groups,i, e. The CHD group (40 cases) and healthy group (50 eases). The plasma level of lipoprotein and apolipoprotein A Ⅰ,B were determined in the two groups. Results: The plasma level of TC, TG,LDL-C and apolipoprotein B in CHD group were higher than that healthy group. The plasma level of HDL-C and the ratio of apolipoprotein A Ⅰ to B in CHDgroup were lower than that healthy group. There were significant difference between the two groups. Conclusion: The ratio between apolipoproteinA Ⅰ and apolipoproteinB(apoAⅠ/apoB) is very important for clinical diagnosis and prognosis of coronary heart disease.
出处 《河北北方学院学报(医学版)》 2005年第6期34-35,共2页 Journal of Hebei North University:Medical Edition
关键词 载脂蛋白 冠心病 血脂 LipoproteinlCoronary heart disease Blood-fat
  • 相关文献

参考文献1

二级参考文献10

  • 1Pearson TA,Criqui MH,Luepha RV, et al.Primer inpreventive cardiology[]..1994
  • 2Li JZ,Chen WX,Wang S,et al.Long-term biologicalvariability of serum lipids[].Chinese Journal of Laboratory Medicine.2002
  • 3Li JZ,Niu QT,Wang S,et al.Variation of serum lipids,lipoproteins and apolipoproteins in the elderly[].Chin J GeriatrMed (Chin).1990
  • 4Weverling-Rijnsburger AW,Blauw GJ,Lagaay AM,et al.Total cholesterol and risk of mortality in the oldest old[].The Lancet.1997
  • 5Grundy S M,Cleeman J I,Rifkind B M,et al.Cholesterol lowering in the elderly population[].Archives of Internal Medicine.1999
  • 6Cleeman JT.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)[].Journal of the American Medical Association The.2001
  • 7Li JZ.Serum lipids (In: Geriatrics progress of China in recent 50 years)[].Chin J Geriatr Med (Chin).1989
  • 8Dislipidemia treatment panel.Recommended guidelines forprevention and treatment of dislipidemia[].Chin J CardiovascDis (Chin).1997
  • 9Shatz U,Masaki K,Yano K,et al.Cholesterol and all causemortality in elderly people from the Honolulu heart program: acohort study[].The Lancet.2001
  • 10Shepherd J.Issues surrounding age: vascular disease in theelderly[].Current Opinion in Lipidology.2001

共引文献11

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部